Thiabendazole-d4
Modify Date: 2025-08-23 17:03:56
Thiabendazole-d4 structure
|
Common Name | Thiabendazole-d4 | ||
|---|---|---|---|---|
| CAS Number | 1190007-20-5 | Molecular Weight | 205.272 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 446.0±37.0 °C at 760 mmHg | |
| Molecular Formula | C10H3D4N3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 226.2±16.9 °C | |
Use of Thiabendazole-d4Thiabendazole-d4 is the deuterium labeled EIDD-1931. EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent anti-virus agent. EIDD-1931 effectively inhibits the replication activity of venezuelan equine encephaliti |
| Name | 2-(1,3-Thiazol-4-yl)(4,5,6,7-2H4)-1H-benzimidazole |
|---|---|
| Synonym | More Synonyms |
| Description | Thiabendazole-d4 is the deuterium labeled EIDD-1931. EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent anti-virus agent. EIDD-1931 effectively inhibits the replication activity of venezuelan equine encephaliti |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 446.0±37.0 °C at 760 mmHg |
| Molecular Formula | C10H3D4N3S |
| Molecular Weight | 205.272 |
| Flash Point | 226.2±16.9 °C |
| Exact Mass | 205.061172 |
| LogP | 2.47 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.740 |
| Storage condition | -20°C |
| 2-(1,3-Thiazol-4-yl)(4,5,6,7-2H4)-1H-benzimidazole |
| 1H-Benzimidazole-4,5,6,7-d4, 2-(4-thiazolyl)- |